T CELL THERAPY MEETS METABOLOMICS WITH TEGs

The innovation of αβT cells engineered to Express a defined γδT cell receptor (TEG) has strong therapeutic potential for combating and eradicating cancer

NEWS

THE SCIENCE

TEGs have strong therapeutic potential for combatting and eradicating both hematological and solid tumors. This approach combines high-affinity γδT cell receptors (TCRs) with αβT cells utilizing their superior proliferation capacity.

EXECUTIVE TEAM

CEO

102319 Nathalie Laarakker _124029.jpg
  • LinkedIn Social Icon

CFO

  • LinkedIn Social Icon

Copyright 2016 GADETA BV

Site design SHIABA